GHK-Cu

Known published concerns and unanswered questions are kept separate so absence of evidence is never presented as reassurance.

Form describes the specific product; route describes how it reaches the body. These are sourced descriptions, not instructions.

Routes shown describe the cited cosmetic or research context only and are not instructions for use.

Status applies to a product, formulation, route, population, and use. It does not apply to a name in the abstract.

1. Jul 22, 2026

   Cosmetic / topical

   GHK-Cu may be used in topical cosmetics, but cosmetics are not FDA-approved before marketing. FDA approval does not exist for injectable GHK-Cu products.

   Specific form or route not separately published in this record.View source

Organize a conversation with a qualified professional without creating a treatment recommendation, dose, or protocol.

• EvidenceWhich human evidence applies to the exact product, form, route, and use being discussed?
• What remains uncertainWhat is known, and what remains uncertain for this specific context?
• RisksWhich important warnings, common effects, and product-quality concerns should be discussed?
• U.S. statusWhat does the U.S. status cover, and what does it not cover?

These profiles share a topic, pathway, product context, or research question. Related does not mean equivalent.

• Acetyl hexapeptide-8Both are used in topical cosmetic peptide products with limited formulation-specific human evidence.

1. 1

   Review of topical GHK

   Mortazavi SM, et al. Topically applied GHK as an anti-wrinkle peptide: advantages, problems and prospective. 2025.

   PubMed-indexed review · Published Jan 1, 2025 · Accessed Jul 22, 2026 · Systematic review

   Open source
2. 2

   FDA authority over cosmetics

   U.S. Food and Drug Administration. FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated.

   U.S. Food and Drug Administration · Published Dec 20, 2022 · Accessed Jul 22, 2026 · Regulatory source

   Open source